Bill114th CongressFiled May 19, 2015Health
H.R. 2438
To amend the Federal Food, Drug, and Cosmetic Act with respect to broader application of Bayesian statistics and adaptive trial designs.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (May 19, 2015)
This bill requires the Food and Drug Administration to issue guidance that addresses using alternative statistical methods, including adaptive trial design and Bayesian methods, in clinical trials and in the development and review of drugs and biological products.
What just happenedMay 22, 2015
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Collins, Chris [R-NY-27](R-NY)Sponsor
1committees4actions1related bills5subjects
- Introduced in HouseMay 19, 2015
- May 22, 2015Committee
Referred to the Subcommittee on Health.
Health Subcommittee - May 19, 2015IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - May 19, 2015IntroReferralIntro-H
Introduced in House
- May 19, 2015IntroReferral1000
Introduced in House